Pharma Companies Amp Up Efforts to Improve Safety of Drug Supply

Written by Economic Development Jobs on December 9, 2016. Posted in Blister card packaging, Clinical trials project management, Secondary pharmaceutical packaging

Over-encapsulation and placebo manufacture

Keeping counterfeit and tainted pharmaceutical products away from patients is a concern shared by all drug companies. In 2012, 64 people were killed as a result of receiving steroid injections that had been contaminated with fungal meningitis. The contaminated medications had come from compounding pharmacies. Compounded pharmaceuticals are individually formulated to meet a patient’s specific needs. In 2013, Congress began looking at ways to improve the e-pedigree serialisation procedures to make it easier to monitor and control the supply of medications that were made in compounding pharmacies to prevent another problem like the one from 2012.

On November 27, 2013, President Obama signed the Drug Quality and Security Act into law. This bill amended the Federal Food, Drug,